Telomerase reactivation is associated with hepatobiliary and pancreatic cancers
- 1 May 2020
- journal article
- review article
- Published by Elsevier BV in Hepatobiliary & Pancreatic Diseases International
- Vol. 19 (5), 420-428
- https://doi.org/10.1016/j.hbpd.2020.04.007
Abstract
No abstract availableThis publication has 82 references indexed in Scilit:
- Expression of telomerase & its significance in the diagnosis of pancreatic cancerIndian Journal of Medical Research, 2012
- hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopesCancer Immunology, Immunotherapy, 2011
- Regeneration of the Exocrine Pancreas Is Delayed in Telomere-Dysfunctional MicePLOS ONE, 2011
- Telomerase gene mutations are associated with cirrhosis formationHepatology, 2011
- A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33Nature Genetics, 2010
- Usefulness of Human Telomerase Reverse Transcriptase in Pancreatic Juice as a Biomarker of Pancreatic MalignancyPancreas, 2009
- Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesisHepatology, 2007
- Telomerase activity, P53 mutation and Ki‐ras codon 12 point mutation of the peripheral blood in patients with hepato pancreato biliary diseasesHPB, 2002
- Telomerase activity is repressed during differentiation along the hepatocytic and biliary epithelial lineages: verification on immortal cell lines from the same originCell Biochemistry and Function, 2001
- Telomerase is strongly activated in hepatocellular carcinoma but not in chronic hepatitis and cirrhosisExperimental & Molecular Medicine, 1998